Following a thorough safety review, the U.S. Food and Drug Administration, the CDC
and ACIP have determined that the recommended pause regarding the use of the J&J COVID
vaccine in the U.S. should be lifted.
The Georgia Department of Public Health (DPH) will again offer J&J vaccine to Georgians aged
18 and older. Details on when administration of the vaccine will begin again in Georgia will be
forthcoming, pending communication with providers.
The federal agencies advised that a warning should be added to the vaccine about the potential
for very rare, but severe blood clots associated with the J&J vaccine. In particular, women under
the age of 50 should be made of aware of the increased risk of thrombosis and
thrombocytopenia syndrome and may choose to receive another vaccine.
At the time J&J vaccine administration was paused, more than 124,000 doses of J&J vaccine
had been safely administered in Georgia. Approximately 211,000 doses are currently in
inventory statewide.
